Holen Sie sich die Stockscreener-App
3.525
53.59%
1.23
Schlusskurs vom Vortag:
$2.295
Offen:
$3.32
24-Stunden-Volumen:
863.06K
Relative Volume:
0.08
Marktkapitalisierung:
$6.86M
Einnahmen:
$29.57M
Nettoeinkommen (Verlust:
$-34.68M
KGV:
-0.00497
EPS:
-708.7214
Netto-Cashflow:
$-7.58M
1W Leistung:
+47.18%
1M Leistung:
+101.80%
6M Leistung:
-96.76%
1J Leistung:
-99.30%
1-Tages-Spanne:
$3.25
$4.20
1-Wochen-Bereich:
$1.865
$4.20
52-Wochen-Spanne:
$1.175
$548.86
Jaguar Health Inc Stock (JAGX) Company Profile
Firmenname
Jaguar Health Inc
Sektor
Branche
Telefon
415-371-8300
Adresse
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
Compare JAGX vs VRTX, MRNA, REGN, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JAGX
Jaguar Health Inc
|
3.525 | 6.86M | 29.57M | -34.68M | -7.58M | -708.72 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-07-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-07-11 | Eingeleitet | Rodman & Renshaw | Buy |
Jaguar Health Inc Aktie (JAGX) Neueste Nachrichten
Jaguar Health sets ex-dividend date for special stock dividend - Investing.com
Jaguar Health (JAGX) Announces Special Stock Dividend Ahead of O - GuruFocus
Jaguar Health Provides Update Regarding Special Stock Dividend - ACCESS Newswire
Jaguar Health sets ex-dividend date for Series R preferred stock dividend - StreetInsider
Jaguar Health's Napo Pharmaceuticals Reports Preliminary Data on Crofelemer for Short Bowel Syndrome (JAGX) - GuruFocus
Jaguar Health unit reports crofelemer study results in bowel syndrome - Investing.com
Jaguar Health unit presents crofelemer SBS-IF study data at ACG 2026 - StreetInsider
Jaguar Health, Inc. (JAGX) Posts Preliminary Positive SBS-IF Data - TradingView
Positive Preliminary Results Presented at Annual American College of Gastroenterology Meeting for Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer - Yahoo Finance
Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend - Lelezard
Jaguar Health, Inc. (JAGX) Sets Record Date for Special Stock Dividend - TradingView
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi - ACCESS Newswire
Jaguar Health Inc Stock Operating Data - GuruFocus
Jaguar Health Inc (FRA:1JA2) Stock Earnings Transcripts - GuruFocus
Jaguar Health Targets Mid-2027 MVID NDA Filing as Crofelemer Intestinal Failure Program Advances - Yahoo Finance
JAGX Stock Jumps As Rare-Disease Pipeline And Special Dividend Draw Traders - Timothy Sykes
A panel will discuss the gut lining beyond nutrition delivered through a vein on Oct. 30. - Stock Titan
JAGX Stock Draws Traders As Rare-Disease Momentum Builds - StocksToTrade
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
JAGX Stock Draws Trader Focus On Crofelemer Progress, Special Dividend - Timothy Sykes
JAGX Stock Draws Traders As Rare-Disease Pipeline Advances - StocksToTrade
Jaguar Health stock gains after special dividend decision - AD HOC NEWS
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi - Yahoo Finance
Jaguar Health (JAGX) Stock Climbs Over 34% After-Hours: What's Going On? - Benzinga
Jaguar Health Reports Approval of All Proposals at August 2025 Annual Meeting of Stockholders - Salinas Californian
Jaguar Health (JAGX) Declares Special Stock Dividend of Series R Convertible Preferred Shares - GuruFocus
Jaguar Health Declares Special Series R Preferred Dividend - TipRanks
Jaguar Health Defers Royalty Payments, Extends $6.22M Note, and Gains Series P Consent - TradingView
Jaguar Health Announces a Special Stock Dividend - Knoxville News Sentinel
Jaguar Health Announces a Special Stock Dividend - ACCESS Newswire
Jaguar Health Announces a Special Stock Dividend - Yahoo Finance
Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer Accepted for Presentation at Annual American College of Gastroenterology Meeting - Yahoo Finance
Form 8K Jaguar Health Inc For: 28 September By Investing.com - Investing.com Nigeria
Jaguar Health Exchanges 481,584 Shares to Cut $3.4 Million of 2021 Note With Streeterville - TradingView
JAGX Stock Whipsaws As Jaguar Health Builds Rare-Disease Story - StocksToTrade
Jaguar Health jumps 32% on rare pediatric disea... - pluang.com
Jaguar Health Stock Surges Friday: What's Happening? - Benzinga
Jaguar Health Stock Surges Friday: What's Happening? - Benzinga
The Secret Behind +2,261% Day Spike - Banyan Hill Publishing
JAGX Stock Whipsaws As Crofelemer Pipeline And Neonorm Dog Advance - timothysykes.com
JAGX Stock Whipsaws As Rare-Disease Catalysts Meet Cash Strain - StocksToTrade
JAGX Stock Pops As Jaguar Health Advances Rare-Disease Pipeline - timothysykes.com
Jaguar Health Cuts $1.68M From 2021 Note in Stock Exchange With Streeterville - TradingView
Jaguar Health Soars 32% as Rare-Disease Pipeline News Meets Thin Post-Split Float - Yahoo Finance
A holder reports 189,617 Jaguar Health (JAGX) shares, with some voting power shared. - Stock Titan
Jaguar Health Stock Slides Thursday: What's Happening? - Benzinga
Viking Therapeutics Sinks 15% After Pricing Upsized $500M Offering; Jaguar Health Tumbles 25% - Yahoo Finance
Viking Therapeutics Sinks 15% After Pricing Upsized $500M Offering; Jaguar Health Tumbles 25% - 24/7 Wall St.
Jaguar Animal Health Reduces Debt Through Equity Exchange - TipRanks
Jaguar Health Exchanges 547,898 Shares to Cut 2025 Note Balance by $5.05 Million - TradingView
Finanzdaten der Jaguar Health Inc-Aktie (JAGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):